Zobrazeno 1 - 10
of 40
pro vyhledávání: '"J M, Gandon"'
Autor:
J. M. Gandon, H. Allain
Publikováno v:
British Journal of Clinical Pharmacology. 54:51-58
Aims Levocetirizine (R-cetirizine), is the active enantiomer of cetirizine, an antihistamine indicated in the treatment of allergic rhinitis and chronic idiopathic urticaria. The purpose of this trial was to analyse the effects of levocetirizine sing
Autor:
Isabelle Berry, H M Lai, Michel Clanet, J M Gandon, M.T. Iba-Zizen, Bruno Brochet, O Sabouraud, Y Rolland, Gilles Edan, E A Cabanis, I. F. Moseley, David Miller, Christian Confavreux, J C Froment, Catherine Lubetzki, Olivier Lyon-Caen
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 62:112-118
OBJECTIVE: To evaluate the efficiency of mitoxantrone in multiple sclerosis. METHODS: Forty two patients with confirmed multiple sclerosis, selected as having a very active disease on clinical and MRI criteria were randomised to receive either mitoxa
Publikováno v:
Journal of Liquid Chromatography & Related Technologies. 19:3119-3124
Usually, determination of DOPEG in plasma by EC-HPLC is always performed after extraction on alumina. This paper presents an extraction on boric acid gel, with good selectivity, reproducibility. In high sensitivity conditions (0.5 nA full scale) an a
Publikováno v:
Biomedicine & Pharmacotherapy. 49:179-186
One of the aims of cognitive psychology is to breakdown complex tasks into their most basic components. The components of explicit (declarative) and implicit (procedural) memory were thus analyzed in undemented, non-depressed Parkinsonian patients un
Publikováno v:
Archives des maladies du coeur et des vaisseaux. 90(8)
The aim of this study was to define the reproducibility and the time required to obtain a stable baseline level of blood pressure (BP) in normotensive volunteers during a phase I trial. Blood pressure was recorded automatically (Dinamap and Marquette
Publikováno v:
Clinical therapeutics. 19(1)
Drugs indicated for use in Alzheimer's disease (AD) must clinically improve the cognitive symptomatology of the disorder, although nonexclusively. From a neurochemical standpoint, these drugs must oppose the multiple processes recognized as stigmata
Publikováno v:
Therapie. 51(2)
Assessment of memory performance is now well established. However, the normal form of assessment does not evaluate memory problems encountered during daily activities, a situation relevant to the evaluation of drug effects on memory components. The p
Publikováno v:
Therapie. 51(2)
Thirty five subjects (age: 45-69 years) with subjective memory loss, without any other neuropsychiatric or somatic disease, were recruited in a phase II study. This double blind randomized versus placebo controlled study compared the effects of minap
Publikováno v:
Journal of neural transmission. Supplementum. 41
Recent data obtained in animals and in humans suggest that both MAO-A and MAO-B inhibitors present cognitive enhancing properties of possible interest in the treatment of cognitive disorders. In addition, the rational for using selegiline as a neurop
Publikováno v:
Amine Oxidases: Function and Dysfunction ISBN: 9783211825211
Recent data obtained in animals and in humans suggest that both MAO-A and MAO-B inhibitors present cognitive enhancing properties of possible interest in the treatment of cognitive disorders. In addition, the rational for using selegiline as a neurop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f6d1416304514e20609e8f92a9fbbea
https://doi.org/10.1007/978-3-7091-9324-2_34
https://doi.org/10.1007/978-3-7091-9324-2_34